Loading...
•
Dec 31, 2024
3D Systems Q4 2024 Earnings Report
3D Systems reported a revenue decline and a net loss in Q4 2024, impacted by a change in accounting estimates in its Regenerative Medicine program.
Key Takeaways
3D Systems' Q4 2024 revenue fell 3% year-over-year to $111 million, largely due to an $8.7 million adjustment tied to its Regenerative Medicine program. The company posted a net loss of $33.7 million and continued efforts to cut costs, while non-GAAP EPS came in at -$0.19.
Q4 revenue declined 3% year-over-year to $111 million.
Reported EPS was -$0.25; non-GAAP EPS was -$0.19.
Gross profit margin decreased to 31.0% from 38.3% last year.
Healthcare revenue dropped 21% while Industrial revenue rose 11%.
3D Systems
3D Systems
3D Systems Revenue by Segment
Revenue by Segment
Healthcare Solutions Revenue
CapyFin.comIndustrial Solutions Revenue
CapyFin.com Forward Guidance
3D Systems expects flat to modest revenue growth for FY2025, aiming for break-even or better adjusted EBITDA by Q4.
Positive Outlook
- New products gaining traction in Healthcare and Industrial markets.
- Full-year 2025 revenue expected to reach $420M to $435M.
- Cost reduction plan expected to deliver $50M in annual savings.
- Geomagic platform divestiture to boost cash reserves.
- Improved utilization rates in installed printer base.
Challenges Ahead
- Accounting estimate change negatively impacted Q4 results.
- Healthcare segment revenue declined sharply year-over-year.
- Operating loss and adjusted EBITDA remained negative.
- Macroeconomic uncertainty impacting capital spending.
- Full impact of cost-saving initiatives won’t materialize until mid-2026.
Revenue & Expenses
Visualization of income flow from segment revenue to net income